IN

VIVO

CLINIC

GENEVA

Pascal Mock :: Dr-Mock

Dr. Pascal 

Mock

FMH gynecology and obstetrics specialist
Extensive training in reproductive medicine and gynecological endocrinology

Read about Video
Dr Mock

Dr. Pascal 

Mock

FMH gynecology and obstetrics specialist
Extensive training in reproductive medicine and gynecological endocrinology

Read about
PROFESSIONALISM

Dr. Pascal Mock

Pascal MOCK, MD, MSc, studied medicine at the Faculty of Medicine of the University of Geneva (Switzerland). 

 After practicing the profession of obstetrician and gynecologist at the University Hospital of Geneva (HUG), he continued his specialization in reproductive medicine in Paris (France) at the Antoine-Béclère hospital leading to a Master in reproductive physiology at the Pierre and Marie Curie University (Paris VI, 1998). Upon returning to Switzerland in 2001, he obtained the FMH certification in reproductive medicine.


 Dr. Mock's area of ​​research is embryo implantation. Between 1999 and 2001 he was director of a Swiss national fund for scientific research, working on the biological activity of a new placental molecule from the insulin family (INSL4). He is the author of several high-level scientific publications on infertility and embryo implantation. He also lectured at the University of Geneva

In 2004 with Martin Velasco, he founded ANECOVA, a Swiss biotechnology company, in order to develop his invention, a new culture system in vivo in medically assisted procreation (ART). His collaboration with EPFL was important during this creative period.

In 2009, he assisted the first baby in the world born from in vivo fertilization made possible using this new system at the Grangettes clinic in Geneva.

PROFESSIONALISM

Scientific publications

1

Scientific articles

  • Relaxin 2000

    Authors:Geoffrey W. Tregear, Richard Ivell, Ross A. Bathgate, John D. Wade
    Editor: Springer Science & Business Media, 29 juin 2013
  • An in vivo culture system for human embryos using an encapsulation technology: a pilot study

    Authors:C. Blockeel, P. Mock, G. Verheyen, N. Bouche, Ph. Le Goff, Y. Heyman, C. Wrenzycki, K. Höffmann, H. Niemann, P. Haentjens, M.J. de Los Santos, M. Fernandez-Sanchez, M. Velasco, P. Aebischer, P. Devroey, and C. Simon (2009)
    Editor: Reprod 2009;24:790–796.
  • Effects of human chorionic gonadotrophin on trophoblast

    Authors:Islami D, Mock P and Bischof P (2001)
    Editor: Seminars in Reproductive Medecine 19, 49-53
  • Simultaneous bilateral tubal pregnancy after intracytoplasmic sperm injection treated by conservative medical treatment : Interest of sonographic follow-up.

    Authors:Mock P, Olivennes F, Doumerc S, Frydman R and Fernandez H.(2001)
    Editor: Eur. J Obstet. Gynecol. Reprod. Biol., 94, 155-157.
  • Expression of pro-EPIL peptides, encoded by the insulin-like4 (INSL4) gene, in chromosomally abnormal pregnancies

    Authors:Mock P, Frydman R, Bellet D, Chassin D, Bischof P, Campana A, Bidart JM. (2000)
    Editor: J. Cl. Endocrinol. Metab., 85, 3941-3944.
  • Choriocarcinoma-like hCG and human chorionic gonadotropin bioactivity during the first trimester of pregnancy.

    Authors:Mock P, Kovalevskaya G, O’Connor D, Campana A. (2000)
    Editor: Hum. Reprod., 15, 2209-2214.
  • Pro-EPIL forms are present in amniotic fluid and maternal serum during normal pregnancy.

    Authors:Mock P, Frydman R, Bellet D, Diawara DA, Lavaissiere L, Troalen F, Bidart JM. (1999)
    Editor: J. Cl. Endocrinol. Metab., 84, 2253-2254.
  • Are women requiring unplanned intrapartum epidural analgesia different in a low-obstetrical risk population?

    Authors:Mock P, Santos-Eggimann B, Bérod ACl, Ditesheim PJ, Paccaud F. (1999)
    Editor: International J. Obst. Anaest., 8, 94-100.
  • Modulation of human chorionic gonodotrophin bioactivity during the first trimester of pregnancy.

    Authors:Mock P, Bischof P, Rivest R, Campana A, Chardonnens D. (1998)
    Editor: Hum. Reprod., 13, 2629-2632.
  • The apparent late half-life of human chorionic gonadotropin (hCG) after surgical treatment for ectopic pregnancy. A new approach to diagnose persistent trophoblastic activity.

    Authors:Mock P, Chardonnens D, Stamm P, Bischof P, Campana A. (1998)
    Editor: Eur. J Obstet. Gynecol. Reprod. Biol., 78, 99-102.
  • Identification of pro-EPIL and EPIL peptides translated from Insulin-like 4 (INSL4) mRNA in human placenta.

    Authors:Bellet D, Lavaissière L, Mock P, Laurent A, Sabourin JC, Bedossa P, Le bouteiller P, Frydman R, Troalen F, Bidart JM (1997)
    Editor: J. Clin. Endocrinol. Metab., 82, 3169-3172.
2

Thesis and dissertations

  • Difficult IVF embryo transfer : Are ovarian steroids implicated ? A Hypothesis (submission to Fertility and Sterility on November 2001)
    El-Minawi AM, Campana A, Mock P.

  • Secretion of human chorionic gonadotrophin (hCG) and gelatinase A (MMP-2) by trophoblastic cells : Up- and down-regulation by relaxin (RLX). Manuscript published in the Proceedings of RELAXIN 2000-3rd International Conference on Relaxin and Related Peptides in March 2001
    Mock P, Meisser A, Wuillemin C, Araman M, Campana A, Bischof P. (2000)

  • Etude de l’expression de early placenta insulin-like (EPIL), produit du gène INSL4, au niveau du placenta et de l’utérus. Mémoire de Diplôme d’Etudes Approfondies de Physiologie de la Reproduction, Responsable scientifique : Professeur Jean-Michel Bidart, Université Paris VI, Pierre et Marie Curie, Paris
    Mock P. (1998)

  • Are women requiring unplanned intrapartum epidural analgesia different in a low-obstetrical risk population?
    Thèse de Doctorat en Médecine, Université de Lausanne, Directeur de Thèse : Professeur Fred Paccaud
    Mock, P. (1998)

3

Excerpts

  • Difficult IVF embryo transfer : Are ovarian steroids implicated ?

    Authors:El-Minawi AM, Campana A, Mock P.
    Editor: A Hypothesis Presentation at the 12th World Congress on in vitro fertilization and molecular reproduction in March 16-19 2001, Buenos Aires, Argentina
  • Localization of tyrosine phosphorylated proteins in human sperm and relation to IVF success.

    Authors:Urner F, Lucas H, Sakkas D, Chardonnens D, Bianchi G, Mock P, Campana A, Leppens-Luisier G.
    Editor: Presentation at ESHRE 2001, Lausanne, Switzerland.
  • Secretion of human chorionic gonadotrophin (hCG) and gelatinase A (MMP-2) by trophoblastic cells : Up-regulation by relaxin (RLX)

    Authors:Mock P, Meisser A, Vuillemin C, Araman M, Campana A, Bischof P.
    Editor: Presentation at the BAS/BFS/SSF Joint Fertility Societies Meeting, EICC, 31st July-2nd August, 2000, Edinburgh, UK
  • Mock intrauterine inseminations (IUI) to study end follicular phase uterine contractility.

    Authors:De Ziegler D, Brioschi PA, Howarth N, Mock P, Fanchin R, Bulletti C.
    Editor: Presentation at the American Society for Reproductive Medicine, 56th Annual Meeting-October 21-25, 2000, San Diego, CA. Published in Fertility and Sterility
  • G1.2/G2.2 : Effect on mouse embryo development and preliminary results in human IVF.

    Authors:Leppens-Luisier, G., Lucas, H., Chardonnens, D., de Ziegler, D., Bianchi, P.G., Mock, P., Campana, A., Urner, F.
    Editor: Presentation at the American Society for Reproductive Medicine, 56th Annual Meeting-October 21-25, 2000, San Diego, CA
  • Homolateral uterine artery impedance is preferentially lowered by the corpus luteum suggesting direct effects of this organ on uterine blood flow through a local circulatory phenomenon.

    Authors:Mock, P., Luedicke, F., Chardonnens, D., Bianchi, G., Bischof, P., De Ziegler, D. And Campana, A.
    Editor: Oral presentation at the 11th World Congress on In Vitro Fertilization and Human Reproductive Genetics in Sydney on May 1999
  • Breast cancer and risk factors : A comparative epidemiological study between a low and a high risk population.

    Authors:Straccia, A.-T., Vlastos, G., Mock, P., Huang, J., Li, H.W., Campana, A., Morabia, A.
    Editor: Poster session at the First European Breast Cancer Conference, Florence, 29th September-3rd October 1998
5

Brevets

Dr Mock

US2004261799 (A1) - Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity

6

Member of Learned Societies

American Society for Reproductive Medecine

Alpha Scientiste in Reproductive Medecine

British Fertility Society

European Society of Human Reproduction and Embroylogy

Société Suisse de Gynécologie et Obstétrique (SSGO)

7

Subsidies 

FNRS (N° 32-59471.99 : 210 000 Frs)

Requérant principal : P. Mock.

Corequérants : Prof. A. Campana, Prof P. Bischof

Early placenta insulin-like (EPIL): research of in vitro biological activities in reproduction.

CONTACT US

Thanks!
×